Michael John Harkins insider trades: GenMark Diagnostics (GNMK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 26, 2021 | GNMK | ↓ Sell | 12,381 | $17.03 | $211K | Direct | Mar 1, 2021 (3d) |
| Jan 27, 2021 | GNMK | ↓ Sell | 1,117 | $14.06 | $16K | Direct | Jan 29, 2021 (2d) |
| Jan 25, 2021 | GNMK | ↓ Sell | 7,338 | $14.22 | $104K | Direct | Jan 25, 2021 (0d) |
| Oct 27, 2020 | GNMK | ↓ Sell | 1,092 | $11.34 | $12K | Direct | Oct 29, 2020 (2d) |
| Jul 28, 2020 | GNMK | ↓ Sell | 1,052 | $17.30 | $18K | Direct | Jul 29, 2020 (1d) |
| Apr 29, 2020 | GNMK | ↓ Sell | 4,124 | $11.64 | $48K | Direct | May 1, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael John Harkins's insider trades
Michael John Harkins is SVP, Sales at GenMark Diagnostics (GNMK). Since Apr 29, 2020, Michael has reported no open-market purchases and 6 sales worth $409K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings), shares returned to the company (1 filing), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GNMK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.